Sign in

CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
300409740
Phone
(415) 651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 17 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-20 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Grant or award +36,750 443,729
2023-11-08 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sale 10b5-1 −200 $17.61 $4K 561,270
2023-11-03 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sale 10b5-1 −541 $17.51 $9K 561,470
2023-11-02 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sale 10b5-1 −3,332 $15.36 $51K 562,011
2023-11-02 Harmon Cyrus Director Sale 10b5-1 −5,000 $15.64 $78K 943,714
2023-11-01 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sale 10b5-1 −6,668 $15.02 $100K 565,343
2023-10-31 Harmon Cyrus Director Sale 10b5-1 −25,000 $12.05 $301K 948,714
2023-10-16 Garland J. Scott Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2023-10-16 Garland J. Scott Director Grant or award · Stock Option (Right to Buy) +14,347 14,347
2023-09-29 Harmon Cyrus Director Sale 10b5-1 −25,000 $12.41 $310K 973,714
2023-09-19 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sale 10b5-1 −20,000 $12.67 $253K 572,011
2023-09-14 BVF PARTNERS L P/IL Director Other acquisition +99,556 99,556
2023-09-12 Graham G. Walmsley Director Purchase +508,130 $9.84 $5.0M 1,668,130
2023-09-12 BVF PARTNERS L P/IL Director Purchase +775,278 $9.84 $7.6M 4,688,954
2023-09-12 BVF PARTNERS L P/IL Director Purchase +677,853 $9.84 $6.7M 3,584,512
2023-09-12 BVF PARTNERS L P/IL Director Purchase +52,801 $9.84 $520K 524,151
2023-09-05 Harmon Cyrus Director Sale 10b5-1 −10,000 $11.62 $116K 998,714
2023-08-31 Harmon Cyrus Director Sale 10b5-1 −15,000 $9.36 $140K 1,008,714
2023-08-16 Harmon Cyrus Director Sale 10b5-1 −15,000 $10.14 $152K 1,023,714
2023-08-16 Harmon Cyrus Director Sale 10b5-1 −15,000 $10.14 $152K 1,023,714

Page 12 of 21 · 402 trades